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Cooperative and Antagonistic Interplay
between PU.1 and GATA-2
in the Specification of Myeloid Cell Fates
of-function (gene targeting) and gain-of-function (ec-
topic expression) experiments (Shivdasani and Orkin,
1996; Glimcher and Singh, 1999). The combinatorial
mechanisms by which these transcription factors spec-
ify distinct cell fates are poorly understood.
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The Ets family transcription factor, PU.1, is necessary1Department of Pharmacology and Physiological
for the generation of myeloid and lymphoid but not ery-Sciences
throid or megakaryocytic lineages of the hematopoietic2 Howard Hughes Medical Institute
system (Scott et al., 1994; McKercher et al., 1996; Singh3 Department of Biochemistry and Molecular Biology
et al., 1999). The blocks to macrophage and B cell devel-The University of Chicago
opment caused by mutation of the PU.1 gene are moreChicago, Illinois 60637
severe than defects in neutrophil and T cell development4 Department of Medicine
(Anderson et al., 1998; DeKoter et al., 1998; Spain et5 Department of Pathology
al., 1999). PU.1/ fetal liver hematopoietic progenitorsHarvard Medical School
proliferate in response to multilineage cytokines suchBrigham and Women’s Hospital
as IL-3, but are impaired in their responsiveness to theBoston, Massachusetts 02115
lineage-restricted cytokines GM-CSF, G-CSF, M-CSF,6 Department of Pathology
and IL-7 (Scott et al., 1997; DeKoter et al., 1998, 2002).7 Department of Molecular Genetics and Cell Biology
PU.1 appears to directly activate transcription of genesThe University of Chicago
encoding subunits of the receptors for these lineage-Chicago, Illinois 60637
restricted cytokines (Singh et al., 1999; DeKoter et al.,
2002). In addition to regulating cytokine responsiveness,
PU.1 directs the differentiation of hematopoietic progen-
itors into macrophages, neutrophils, and B lymphocytesSummary
(DeKoter et al., 1998; DeKoter and Singh, 2000).
Although PU.1 is expressed in mast cells (Galson etPU.1 and GATA transcription factors appear to antago-
al., 1993), its requirement in mast cell development hasnize each other’s function in the development of dis-
not been genetically analyzed. Mast cell progenitors cantinct lineages of the hematopoietic system. In contrast,
be enumerated by colony-forming assays using IL-3 andwe demonstrate that PU.1, like GATA-2, is essential for
SCF (Lantz and Huff, 1995). Such progenitors, derivedthe generation of mast cells. PU.1/ hematopoietic
from bone marrow or fetal liver, can also be expandedprogenitors can be propagated in IL-3 and differentiate
into cell lines using IL-3. Under these culture conditions,into mast cells or macrophages upon restoration of
the progenitors give rise to immature mast cells repre-PU.1 activity. Using these progenitors and a condition-
senting various stages of development (Galli et al., 1982).ally activatable PU.1 protein, we show that PU.1 can
These cells contain variable numbers of cytoplasmicnegatively regulate expression of the GATA-2 gene. In
granules and express c-kit as well as the high-affinitythe absence of GATA-2, PU.1 promotes macrophage
IgE receptor, FcRI. Many of these cell lines express
but not mast cell differentiation. Reexpression of
transcripts encoding the mast cell proteases mMC-CPA
GATA-2 in such progenitors enables the generation
and mMCP-5, suggesting these protease genes are in-
of mast cells. We propose a developmental model in duced early in mast cell development (Reynolds et al.,
which cooperative function or antagonistic crossregu- 1989; McNeil et al., 1991). Given that PU.1 does not
lation by PU.1 of GATA-2 promotes distinct myeloid regulate expression of the IL-3 receptor (DeKoter et al.,
cell fates. 1998), we reasoned that it should be possible to analyze
the function of PU.1 in mast cell differentiation by ex-
Introduction panding mutant hematopoietic progenitors in IL-3.
The transcription factor GATA-2, like PU.1, is essential
The hematopoietic system develops from a self- for the development of multiple hematopoietic lineages
renewing stem cell (HSC) that generates a hierarchical but appears to regulate the survival/proliferation of HSC
array of developmental intermediates consisting of and multipotential progenitors (Tsai et al., 1994). GATA-2
multipotent and lineage-committed progenitors which has also been shown to be specifically required for mast
differentiate into erythrocytes, megakaryocytes, and cell differentiation by expanding yolk sac progenitors
cells of the innate and adaptive immune system. It repre- from GATA-2 null embryos in IL-3 and SCF (Tsai and
sents a leading developmental system for analyzing reg- Orkin, 1997). Under these conditions, wild-type yolk sac
ulatory proteins that specify distinct cell fates. Structur- cells give rise to both macrophages and mast cells.
ally diverse transcription factors have been shown to However, GATA-2/ yolk sac progenitors generate
play critical roles in lineage specification via both loss- only macrophages. This demonstrates that GATA-2 is
required for the generation of mast cells but dispensable
for macrophage differentiation. GATA-2 expression is8 Correspondence: hsingh@midway.uchicago.edu
highest in proliferating mast lineage cells and is down-9Present address: Children’s Hospital, Harvard Medical School, Bos-
ton, Massachusetts 02115. regulated in differentiated tissue mast cells (Jippo et al.,
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Figure 1. PU.1 Is Required for the Development of Mast Cells
(A) Day 16.5 PU.1/ or / embryonic dorsal skin sections were stained with acidified toluidine blue. Mature mast cells (MC) are recognized
by metachromatic staining of their granules. PU.1/ embryos contained approximately 400 mast cells/cm of dorsal subcutaneous tissue
(left panel) whereas PU.1/ embryos contained no observable mast cells (right panel).
(B) IL-3-dependent cell lines established from day 14.5 PU.1/ (left panels) or / (right panels) hematopoietic progenitors. Cells cultured
in the presence of either IL-3 or IL-3 and SCF were stained with toluidine blue. Original magnification 1000.
1996). The latter cells express the related factor GATA-1. that in this lineage the two factors may function coopera-
tively rather than antagonistically to specify cell fate.Consistent with its pattern of expression, GATA-1 is not
required for mast cell development (Pevny et al., 1995). In this study, we establish a requirement for PU.1 in
the development of mast lineage cells. Using PU.1/Nevertheless, it appears to regulate the mature pheno-
type of tissue mast cells (Harigae et al., 1998). hematopoietic progenitor lines, we uncover evidence
for cooperative and antagonistic interplay between PU.1Recently, PU.1 and GATA family transcription factors
have been shown to antagonize each other’s activities and GATA-2 that results in specification of alternate cell
fates, mast cells, or macrophages. We demonstrate that(Rekhtman et al., 1999; Zhang et al., 1999, 2000; Nerlov
et al., 2000). PU.1 and GATA-1,2 have been shown to PU.1 antagonizes GATA-2 expression during macro-
phage differentiation, but functions cooperatively withphysically interact through their DNA binding domains.
Such interaction results in mutual antagonism of their GATA-2 to specify the mast cell fate. This leads us to
propose a developmental model in which reciprocal an-transactivating abilities when they are ectopically ex-
pressed in heterologous cell lines. It has been suggested tagonism between PU.1 and GATA family factors speci-
fies macrophage or erythrocyte fates, whereas coopera-that this direct antagonism between PU.1 and GATA-1
proteins, which results in inhibition of GATA-1 DNA bind- tive interaction between PU.1 and GATA-2 is essential
for mast cell development.ing activity, could account for the block to erythroid
differentiation caused by overexpression of PU.1 (Zhang
et al., 2000). Consistent with this explanation, PU.1- Results
mediated inhibition of erythropoiesis in Xenopus embryos
can be suppressed by overexpression of GATA-1 PU.1 Regulates the Proliferation and Differentiation
of Mast Cell Progenitors In Vivo(Rekhtman et al., 1999). Conversely, ectopic expression
of GATA-1 inhibits myeloid differentiation that is depen- During mouse embryogenesis, mast cells can be ob-
served in subcutaneous tissues by day 15.5 of develop-dent on PU.1 (Nerlov et al., 2000). In this case, it has
been argued that the interaction of GATA-1 with PU.1 ment (Kitamura et al., 1979). Since the targeted PU.1
null mutation results in late embryonic lethality (Scott etprevents recruitment of coactivators to PU.1-regulated
myeloid genes (Zhang et al., 1999). Although GATA-2 al., 1994), we examined dermal tissue from day 16.5
PU.1/ fetuses for the presence of mast cells. Thesehas been shown to interact with PU.1 and the two factors
can mutually antagonize each other’s transactivation cells can be visualized by metachromatic staining of
their basophilic granules with toluidine blue. Similarfunctions, the biological relevance of this inhibitory inter-
action remains unclear. Furthermore, mast lineage cells numbers of mast cells were observed in the dermis of
PU.1 / and / fetuses (Figure 1A, left panel, andexpress both PU.1 and GATA-2, raising the possibility
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data not shown). Strikingly, no mast cells were detect- the expression of various mast cell-specific proteases,
which are normally found in the granules of immatureable in tissue from PU.1/ fetuses (Figure 1A, right
mast cells in vitro. Immunocytochemistry revealed thatpanel). Thus, the PU.1 gene is essential for mast cell
unlike their PU.1/ counterparts, PU.1/ cells faileddevelopment, in vivo.
to express mMCP-5 protein (Figure 2A). This defect inThe defect in mast cell development caused by the
mMCP-5 expression was due to a failure to express thePU.1 mutation may be due to either a failure to generate
gene (Figure 2B). Transcripts encoding other mast cellmast cell progenitors or a failure of such progenitors
proteases, mMCP-2 and mMCP-4, were also absent into undergo differentiation. To address this issue, we
PU.1/ cells (Figure 2B and data not shown, respec-performed methylcellulose colony-forming assays in the
tively). Transcripts for mMC-CPA, a protease expressedpresence of IL-3, SCF, or their combination. PU.1/
early in mast cells, were detectable in PU.1/ cells,fetal liver progenitors formed three distinct types of my-
albeit at approximately 20-fold reduced levels. Thus,eloid colonies in IL-3 (mast, granulocyte/macrophage,
PU.1/ cells are unable to accumulate secretory gran-and mixed). As reported previously, SCF synergized with
ules in part because of a failure to express genes encod-IL-3 to induce mast cell colony formation (Lantz and
ing the protease components induced early in mast de-Huff, 1995). The PU.1 mutation caused a severe reduc-
velopment.tion (approximately 100-fold) in the number of IL-3-
We next determined whether loss of PU.1 affects theresponsive progenitors (see supplemental data at http://
developmental induction of FcRI expression, in addi-www.immunity.com/cgi/content/full/17/5/665/DC1).
tion to blocking granule biogenesis. Analysis ofFurthermore, the few colonies that did form consisted
PU.1/ cells revealed an absence of surface expres-of immature cells lacking morphological characteristics
sion of FcRI, compared to their heterozygote counter-of mast cells, macrophages, and neutrophils (data not
parts (Figure 2C). The block in surface expression ofshown). These results suggest that PU.1 is important
FcRI was due to a failure to accumulate transcriptsfor the survival/proliferation of mast cell progenitors in
encoding the FcRI and  subunits (Figure 2D). Inter-vivo and is also required for their differentiation.
estingly, FcRI transcripts were detected at equal lev-
els by RT-PCR in both PU.1/ and/ cell lines (dataEstablishment of IL-3-Dependent PU.1/
not shown). Thus, PU.1 is required for expression ofProgenitor Cell Lines
genes encoding the  and  subunits of FcRI as wellTo analyze PU.1 function in mast cell differentiation, IL-
as mast cell-specific proteases.3-dependent cell lines were established from PU.1/
and / hematopoietic progenitors. Previous studies
Retroviral Transduction of PU.1 into the Mutant Cellshave shown that IL-3 promotes the generation of imma-
Induces Mast Cell and Macrophage Differentiationture mast cells from bone marrow or fetal liver derived
To determine if the IL-3-dependent PU.1/ cells arehematopoietic progenitors. Hematopoietic progenitors
developmentally competent to undergo mast cell differen-(Lin) were isolated from day 14.5 PU.1/ and /
tiation, we transduced them with a retroviral vector con-fetal liver and cultured in IL-3 (see Experimental Proce-
taining PU.1 cDNA and the gene for enhanced greendures). Immature mast cells were detectable in PU.1/
fluorescent protein (MSCV-EGFP-PU.1, see Experimen-cultures after 21 days and predominated after 60 days
tal Procedures). To enrich for productively infected cells,(Figure 1B, left panel). These cells possessed an abun-
we FACS sorted on the basis of GFP expression. Twodant cytoplasm containing varied numbers of basophilic
weeks after FACS sorting, mutant cells transduced withgranules characteristic of immature mast cells. They
MSCV-EGFP-PU.1, but not the control vector (MSCV-
exhibited small nuclei in relation to their cytoplasm. The
EGFP), gave rise to a subpopulation that expressed both
combination of SCF and IL-3 induced further differentia-
GFP and FcRI (Figure 3A). The MSCV-EGFP-PU.1-
tion of the PU.1/ cells, as evidenced by increased infected cultures contained morphologically distinguish-
accumulation of secretory granules (Figure 1B). Even able mast cells with some metachromatic cytoplasmic
though IL-3-responsive progenitors were severely re- granules (Figure 3B, right panel). Granule accumulation
duced by the PU.1 mutation, they expanded readily in in such cells was further stimulated by culturing in SCF
IL-3, facilitating the establishment of PU.1/ cell lines. and IL-3 (data not shown). Thus, PU.1/ cells can
The mutant cells showed characteristics of myeloid pro- be induced to differentiate into immature mast cells by
genitors (Figure 1B, right panel). They exhibited large reexpression of PU.1. It should be noted that a fraction
lobular nuclei and reduced cytoplasm with many vacu- of the GFP cells expressing PU.1 differentiated into
oles. Some of these vacuoles contained material which macrophages (Figure 3B, right panel). However, the
stained faintly with toluidine blue. Unlike their PU.1/ macrophages did not proliferate in IL-3 and therefore
counterparts, PU.1/ cells did not differentiate further mast cells were selectively expanded. In order to confirm
in response to IL-3 and SCF (Figure 1B). Western analy- that the IL-3-dependent PU.1/ cells also had macro-
sis confirmed the absence of PU.1 protein in the phage potential, we transduced them with PU.1 and
PU.1/ cells (see below). These mutant cells appeared cultured in M-CSF on S17 stromal cells instead of in
to be blocked for mast cell differentiation at an early IL-3. Under these conditions, the PU.1-transduced pro-
developmental stage. genitors efficiently differentiated into macrophages but
not mast cells (Figure 3C, right panel). Collectively, these
PU.1/ Cells Are Defective for Secretory Granule results suggest that the PU.1/ cells represent multi-
Biogenesis and FcRI Expression potential myeloid progenitors which can be induced to
To analyze the molecular defect in secretory granule differentiate into mast cells or macrophages upon reex-
pression of PU.1.biogenesis caused by the PU.1 mutation, we examined
Immunity
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Figure 2. PU.1 Is Required for the Expression of Mast Cell Proteases and FcRI
(A) Immunocytochemical staining of mMCP-5 in IL-3-dependent PU.1/ and / cell lines. Red staining of cytoplasm indicates presence
of mMCP-5 in PU.1/ cells.
(B) Northern blot analysis of transcripts encoding mast cell-specific proteases mMCP-5, mMCP-2, and mMC-CPA.
(C) FACS analysis of IL-3-dependent PU.1/ and PU.1/ cells stained with IgE (bold line).
(D) Northern blot analysis of transcripts encoding the  and  subunits of the high-affinity IgE receptor, FcRI.
Generation of PU.1/ Cells Expressing Developmental Potential of PUER-Transduced
PU.1/ ProgenitorsConditionally Activatable PU.1 Proteins
To examine how PU.1 regulates the specification of dis- In the absence of tamoxifen (OHT), the PUER protein
displayed basal activity as it induced low-level Mac-1tinct myeloid cell fates (mast cell versus macrophage),
an inducible version of the protein was generated by expression on the surface of PU.1/ progenitors (Fig-
ure 4C). The gene encoding the CD11b subunit of Mac-1fusion to the ligand binding domain of the estrogen re-
ceptor (PUER, Figure 4A). The estrogen receptor domain appears to be directly regulated by PU.1 since its pro-
moter contains a functionally important binding site foris a variant (ERTM) that is preferentially regulated by
tamoxifen (OHT). Two mutant PUER derivatives were PU.1 and its expression is PU.1 dependent (Chen et al.,
1993; DeKoter et al., 1998). The basal activity of the PU.1also generated by fusing the transactivation (TA) and
PEST regions of PU.1 (C111) or the Ets DNA binding fusion protein did not, however, induce morphological
differentiation (Figure 4D). When the PUER-expressingdomain (N160) to the ERTM segment. An IL-3-depen-
dent PU.1/ progenitor cell line was transduced with cells were cultured in 100 nM OHT, they differentiated
into macrophages (Figure 4D) expressing high levels ofretroviral vectors expressing either the full-length PU.1
fusion protein or the mutant derivatives. Initially, pools Mac-1 (Figure 4C) and the macrophage colony stimulat-
ing factor receptor (data not shown). As shown pre-of stably transduced cells were selected and then clones
were obtained by limiting dilution. The clones used for viously, PU.1-induced macrophage differentiation re-
quired both the Ets DNA binding domain and thein-depth analysis had the same properties as the pools
from which they were derived. Expression of the individ- transactivation domain (Fisher et al., 1998). The cells
expressing the mutant fusion proteins (C111 orN160)ual PU.1 fusion proteins was examined by Western blot-
ting (Figure 4B). The full-length fusion protein was ex- did not undergo differentiation upon tamoxifen treat-
ment (data not shown). These control cell lines demon-pressed at higher levels compared with its C111 and
N160 derivatives. strate that differentiation of PU.1/ progenitors into
Regulation of Myeloid Cell Fates by PU.1 and GATA-2
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Figure 3. Expression of PU.1 in IL-3-Depen-
dent Mutant Cells Induces Mast Cell and
Macrophage Differentiation
(A) PU.1/ cells were infected with either
MSCV-EGFP or MSCV-EGFP-PU.1 retrovirus
and cultured in complete medium with IL-3
for 2 days. Infected cells were enriched by
FACS sorting for green fluorescence protein
and analyzed for FcRI expression after 14
days of culture in IL-3.
(B) Toluidine blue staining of PU.1/ cells
from the experiment described above (origi-
nal magnification 1000). Right panel shows
immature mast cells as well as a macrophage.
(C) PU.1/ cells after infection with either
MSCV-EGFP or MSCV-EGFP-PU.1 retrovirus
were cultured in M-CSF on S17 stromal cells
for 14 days and analyzed by Wright staining.
macrophages is not simply due to tamoxifen treatment focused our analysis on GATA-2 since it is essential for
mast cell but not macrophage development. Intriguingly,and/or expression of the ERTM protein segment. The
activated PUER protein also inhibited IL-3-dependent whereas the PU.1/ and / cells expressed the
GATA-2 protein, the PUER cells did not (Figure 4F). Thisproliferation of the PU.1/ cells. When cultured in 100
nM OHT, the PUER cells failed to proliferate after com- suggested that PU.1 can downregulate GATA-2 expres-
sion, and such antagonistic crossregulation may resultpleting one round of cell division (data not shown). It
should be noted that 100 nM OHT treatment of the pa- in a loss of mast cell developmental potential.
rental PU.1/ cells neither affected their proliferation
in IL-3 nor induced their differentiation. Furthermore, PU.1 Downregulates Expression of the GATA-2 Gene
during Macrophage Differentiationneither theC111 nor theN160 fusion proteins induced
growth arrest upon OHT treatment. Thus, it is the induc- The expression status of the GATA-2 gene in the PUER
cells was analyzed by RT-PCR (Figure 5A). As was thetion of PU.1 activity by OHT that results in inhibition
of IL-3-dependent proliferation of PU.1/ progenitors case for GATA-2 protein, the PUER cells did not express
the GATA-2 gene. Intriguingly, expression of the GATA-2and their differentiation into macrophages.
Surprisingly, activation of the PUER protein in gene was maintained in N160 cells but downregulated
in the C111 cells (Figure 5A). As shown earlier, bothPU.1/ progenitors did not result in the generation of
mast cells. As described above, the mutant progenitors, mutant fusion proteins are expressed at equivalent lev-
els and neither is capable of promoting myeloid differen-when infected with a retroviral vector which constitu-
tively expresses PU.1, can give rise to both macro- tiation. Downregulation of the GATA-2 gene by PU.1
represents specific antagonistic crossregulation sincephages and mast cells. We therefore reasoned that ex-
pression of high levels of the PUER protein may have PUER did not impair expression of other key hematopoi-
etic transcription factor genes such as AML1, c-Myb,altered the developmental capacity of the cells, due to
its basal activity. Indeed, the PUER fusion protein was and SCL/Tal-1 (Figure 5A). In these cells, the high levels
of the PUER protein and its basal activity appear to beexpressed at considerably higher levels than PU.1 in the
mutant cells after retroviral transduction (Figure 4E). We sufficient to downregulate GATA-2. The PUER protein
Immunity
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Figure 4. A Conditionally Activatable PU.1 Protein Induces Macrophage but Not Mast Cell Differentiation
(A) Schematic depicting the structures of MSCV-PAC retroviral vectors encoding various PU.1 derivatives fused to the tamoxifen responsive
ligand binding domain of the estrogen receptor (ERTM).
(B) IL-3-dependent PU.1/ cells were infected with the indicated vectors, and pools of stably tranduced cells were selected using puromycin.
Expression levels of the three PUER protein derivatives were analyzed by Western blotting.
(C) FACS analysis of Mac-1 expression on a representative PUER clonal line isolated from the pool described in (B). Cells were cultured in
the absence (thin line) or presence of 100 nM OHT (thick line) for 3 days before FACS analysis. Dashed line represents Mac-1 expression on
the parental PU.1/ progenitor cell line.
(D) Analysis of macrophage differentiation induced by the PUER protein using Wright staining (original magnification 1000). Cells described
in (C) were cultured in 100 nM OHT for 7 days prior to cytochemical analysis.
(E) Western analysis of PU.1 and PUER expression in PU.1/ progenitor cells after retroviral transduction. PU.1 expression was analyzed
after transduction with MSCV-EGFP-PU.1 and sorting for GFP cells (see legend to Figure 3). PUER cells are described in (C).
(F) Analysis of GATA-2 expression by Western blotting in the indicated IL-3-dependent cell lines.
was also expressed in PU.1/cells using a GFP-based 5B). Furthermore, a PUER derivative that carries muta-
tions in the recognition helix of the ets DNA bindingretroviral vector system. This enabled isolation of PUER-
expressing cells (GFP) immediately after retroviral domain still downregulated the GATA-2 gene (data not
shown). Thus the PU.1-mediated downregulation of thetransduction. In these experiments, we observed OHT-
inducible downregulation of the GATA-2 gene (Figure GATA-2 gene is neither dependent on the Ets DNA bind-
Regulation of Myeloid Cell Fates by PU.1 and GATA-2
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Figure 5. PU.1 Can Downregulate GATA-2
Gene Expression Thereby Causing a Block to
Mast Cell Development
(A) RT-PCR analysis of transcripts encoding
various hematopoietic transcription factors in
the indicated IL-3-dependent cell lines (see
Figure 4B).
(B) RT-PCR analysis of GATA-2 expression
in PU.1/ progenitors after transduction of
PUER. The mutant progenitor cells were
transduced with an MSCV retroviral vector
expressing PUER and GFP. Two days after
infection, the cells were sorted for GFP ex-
pression and then cultured in the absence ()
or presence () of 100 nM OHT for 24 hr be-
fore isolating RNA.
(C) RT-PCR analysis of GATA-2 expression
in macrophages generated from wild-type
progenitors or by transduction of PU.1 into
PU.1/ cells (see legend to Figure 3C).
(D) RT-PCR analysis of GATA-2 expression in
mast lineage cells (PU.1/) and PU.1/
progenitors induced to differentiate into mast
cells by retroviral transduction of PU.1 (see
legend to Figures 3A and 3B).
(E) FACS analysis of FcRI and GFP expres-
sion inC111 orN160 cells after superinfec-
tion with MSCV-EGFP-PU.1 retrovirus. Virally
transduced cells were propagated in IL-3 for
14 days prior to FACS analysis.
ing domain nor its DNA binding activity (Figure 5A and Cooperative Interplay between PU.1 and GATA-2
in the Specification of Mast Cell Fatedata not shown).
The above experiments suggested that PU.1 may As stated above, we hypothesized that PU.1 inhibition
of GATA-2 gene expression precludes mast cell differen-physiologically downregulate the expression of the
GATA-2 gene during the differentiation of myeloid pro- tiation and therefore restricts the developmental capac-
ity of myeloid progenitors. This proposal is consistentgenitors into macrophages. To examine this possibility,
expression of the GATA-2 gene was analyzed after in- with the sustained expression of the GATA-2 gene dur-
ing mast cell development but its downregulation duringducing the differentiation of PU.1/ progenitors into
macrophages by retroviral transduction with PU.1 and macrophage differentiation (Figures 5A and 5C).
We tested the hypothesis that PU.1 functions in com-culturing the cells with M-CSF and the stromal cell line
S17 (see Figure 3C). GATA-2 expression was down- bination with GATA-2 to specify the mast cell fate using
two distinct experimental strategies. In the first ap-regulated in PU.1-rescued macrophages derived from
PU.1/ progenitors as well as in macrophages gener- proach, we took advantage of the C111 and N160
cells which differentially express GATA-2, but are inca-ated from wild-type hematopoietic progenitors (Figure
5C). Importantly, GATA-2 expression was sustained in pable of differentiating into mast cells or macrophages
because they lack intact PU.1. To test their mast lineagePU.1/ cells that were induced to become mast cells
(see Figures 3A and 3B) after retroviral transduction of developmental potential, the C111 and N160 cells
were transduced with the PU.1 retrovirus. Stably trans-PU.1 (Figure 5D). These experiments demonstrate that
PU.1 specifically downregulates the expression of the duced cells were sorted on the basis of GFP expression
and cultured in IL-3 for 2 weeks. As stated above, mastGATA-2 gene during the differentiation of myeloid pro-
genitors into macrophages but not mast cells. cells are selectively expanded under these conditions
Immunity
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since they continue to proliferate in IL-3 whereas macro-
phages do not. Expression of PU.1 in the N160 cells,
which retain GATA-2 expression (Figure 5A), resulted in
the generation of immature mast cells that expressed
the high-affinity IgE receptor (FcRI, Figure 5E) and ac-
cumulated secretory granules in their cytoplasm (data
not shown). No mast cells were generated by expression
of PU.1 in the C111 cells which lack GATA-2 expres-
sion. These results demonstrate that loss of GATA-2
expression eliminates mast cell developmental po-
tential.
A second test of our hypothesis entailed reexpression
of GATA-2 in the PUER cells. To perform this test, we
superinfected the PUER cells with retroviruses express-
ing either GFP or hGATA-2 along with GFP (Figure 6).
Stably transduced pools of control (PUERGFP) or
GATA-2-expressing PUER (PUERGATA-2) cells were
then cultured in the absence or presence of 100 nM OHT.
Like the parental PUER cells (Figure 4C), the control
PUERGFP cells generated macrophages upon induc-
tion with 100 nM OHT. They did not express FcRI or
accumulate secretory granules characteristic of mast
cells (data not shown). In striking contrast, activation of
PU.1 in the PUERGATA-2 cells induced the expression
of the mast cell marker FcRI (Figure 6B, right panel).
The generation of mast cells by the combined action of
PU.1 and GATA-2 was documented by the following
criteria: (1) induction of FcRI expression (Figure 6B);
(2) maintenance of c-kit expression on a subset of the
cells after induction of PU.1 activity (data not shown);
(3) accumulation of secretory granules in the cytoplasm
(Figures 6C and 6D); and (4) sustained proliferation in
IL-3. It should be noted that, in the presence of 100
nM OHT for 7 days, the PUERGATA-2 cells generated
mostly macrophages and relatively few morphologically
distinct mast cells (Figure 6C). However, because imma-
ture mast cells retain the ability to proliferate in IL-3,
they represented the predominant cell type after an ad-
ditional 14 days of culture (Figure 6D). These experi-
ments demonstrate that the induction of PU.1 activity
Figure 6. PU.1 Cooperates with GATA-2 to Specify the Mast Cellin a multipotential hematopoietic progenitor, under con-
Fateditions which sustain GATA-2 expression, enables the
(A) RT-PCR analysis of GATA-2 transcripts in the indicated cells. Aspecification of the mast cell fate.
PUER clone (see Figure 4C) was superinfected with either a control
MSCV-EGFP retrovirus or a hGATA-2 encoding derivative to estab-
lish the PUEREGFP and PUERGATA-2 cell lines, respectively
Discussion (see Experimental Procedures).
(B) FACS analysis of PUERGATA-2 cells in the absence (left panel)
or presence (right panel) of 100 nM OHT. Cells were cultured for 7PU.1 is a hematopoietic transcription factor that is
days with OHT prior to FACS analysis.uniquely required for the development of macrophages
(C) Wright staining of the PUERGATA-2 cells after 7 days of cultureand neutrophils, as well as B and T lymphocytes (Singh
in OHT (original magnification 1000). Arrow indicates granulated
et al., 1999). Although PU.1 is expressed in mast cells cell with immature mast cell morphology.
and implicated in regulating mast cell-specific gene ex- (D) Toluidine blue staining of PUERGATA-2 cells after 21 days of
culture in OHT.pression (Henkel and Brown, 1994), its developmental
function in the mast cell lineage remained to be ex-
plored. Using a previously described targeted mutation
of the PU.1 gene (Scott et al., 1994), we demonstrate PU.1 Is Required for Proliferation as Well as
that PU.1 functions to regulate both the proliferation as Differentiation of Mast Cell Progenitors
well as differentiation of mast cell progenitors. PU.1 Disruption of the PU.1 gene results in the complete ab-
is required for early events in mast cell differentiation sence of embryonic dermal mast cells as well as a severe
including granule biogenesis and expression of FcRI. reduction in IL-3 and SCF responsive hematopoietic
Furthermore, our results demonstrate that PU.1 func- progenitors in the fetal liver that give rise to mast cells.
tions in concert with GATA-2 to induce multipotential We have previously shown that PU.1/ hematopoietic
progenitors can proliferate in vitro in response to theprogenitors to differentiate into immature mast cells.
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multilineage cytokines IL-3, IL-6, and SCF, but are unre- tiate into macrophages. Using a similar in vitro culture
system (expansion of PU.1/ fetal liver progenitors insponsive to the myeloid-specific cytokines GM-CSF,
G-CSF, and M-CSF (DeKoter et al., 1998). Here, we dem- IL-3), we have been able to analyze the role of PU.1 in
mast cell differentiation. This is made possible by theonstrate that SCF promotes colony formation by PU.1/
progenitors in the presence of IL-3 (see supplemental fact that PU.1/ progenitors unlike GATA-2 / pro-
genitors cannot differentiate into either macrophagesdata at http://www.immunity.com/cgi/content/full/17/5/
665/DC1). Furthermore, PU.1/progenitors expanded or mast cells in the presence of IL-3. Using this system
and gain-of-function experiments, we demonstrate thatwith IL-3 express c-kit albeit at lower levels than their
heterozygous counterparts and can proliferate in re- both PU.1 and GATA-2 are required for mast cell differ-
entiation. The DNA binding as well as transactivationsponse to SCF (data not shown). Therefore, the reduc-
tion in mast cell progenitors caused by the PU.1 muta- domains of PU.1 are essential for promoting mast cell
differentiation (Figure 5). We suggest that PU.1 andtion is not simply due to an absence of c-kit expression
or signaling. GATA-2 may coregulate gene expression in mast cell
precursors. Transcription of the mMC-CPA gene, anThe ability to culture PU.1/ hematopoietic progeni-
tors in IL-3 enabled a detailed analysis of the block early marker of mast lineage cells, appears to require
both PU.1 (Figure 2B) and a GATA factor (Zon et al.,to mast cell differentiation. PU.1/ progenitors are
defective in secretory granule biogenesis (Figure 1). The 1991). Similarly, transcription of the IL-4 gene in mast
cells appears to be regulated by an enhancer which ismutant cells contain small vesicles, but are largely de-
void of granular material. The defect in granule biogene- PU.1- and GATA-factor dependent (Henkel and Brown,
1994). These observations suggest that mast cell genesis is in part due to the failure to express genes encoding
granule components. In particular, genes encoding mast expression may be driven by combinatorial action of
PU.1 and a GATA factor on regulatory regions containingcell proteases mMCP-2, mMCP-4, and mMCP-5 are not
expressed in the mutant cells (Figure 2). Expression of binding sites for both factors. GATA-2 rather than
GATA-1 is most probably regulating early mast cell genemMC-CPA, although detectable, is reduced approxi-
mately 20-fold. By comparison, the earliest defined mast expression since the former is essential for development
(Tsai and Orkin, 1997) and is expressed at higher levelscell precursors express transcripts for the proteases
mMC-CPA, mMCP-2, and mMCP-4 and contain a few in immature mast cells (Harigae et al., 1998). Importantly,
these considerations imply that PU.1 and GATA-2 dosecretory granules (Rodewald et al., 1996). Culturing
of such precursors in IL-3 and SCF promotes further not antagonize each other’s transactivating functions in
mast cells (see below).differentiation accompanied by induction of FcRI tran-
scripts and surface expression of FcRI. PU.1/ pro-
genitors, cultured in IL-3 or the combination of IL-3 and Regulatory Interactions between PU.1 and GATA
SCF, neither express FcRI on their surface nor tran- Factors in Erythroid/Myeloid Differentiation
scripts encoding the FcRI and  subunits (Figure 2), Multipotential erythroid/myeloid progenitors appear to
consistent with an early block to mast cell differentiation. express high levels of GATA-2 and low levels of GATA-1
On the basis of this phenotypic comparison, PU.1/ and PU.1 (Akashi et al., 2000). Differentiation of these
progenitors arrest before the mast cell precursor stage. progenitors into myeloid cells such as macrophages is
The block to mast cell development induced by the preceded by the induction of PU.1 expression and the
PU.1 mutation appears to be at the level of a multipoten- downregulation of GATA-1 and GATA-2 expression
tial progenitor, i.e., prior to specification along the mast (Cheng et al., 1996) and Figure 5. In contrast, erythroid
lineage. First, of the various mast cell markers examined, differentiation is accompanied by the induction of
the IL-3-dependent PU.1/ progenitors express de- GATA-1, and a low level of PU.1 expression. Develop-
tectable transcripts of only one, mMC-CPA. Second, ment of erythrocytic precursors is dependent on both
the PU.1/ progenitor cells transduced with PU.1 GATA-1 and GATA-2 (Pevny et al., 1995; Tsai and Orkin,
cDNA give rise to mast cells as well as macrophages 1997) and occurs independent of PU.1 expression (Scott
(Figure 3). Most importantly, a clonal line of PU.1/ et al., 1994). Furthermore, ectopic GATA-1 expression
progenitors harboring a conditionally activatable PUER in an avian myelomonocytic cell line can induce repro-
fusion protein generates macrophages and mast cells gramming into an erythroblast (Kulessa et al., 1995). In
in the presence of GATA-2 (Figure 6). Thus the IL-3- the avian system, GATA-1 can inhibit PU.1 expression
dependent PU.1/ cells represent multipotential my- (McNagny et al., 1998). Recently, ectopic expression of
eloid progenitors and provide a unique system for ana- PU.1 in Xenopus embryos has been shown to inhibit
lyzing distinct myeloid differentiation pathways. erythropoiesis which is overcome by elevated expres-
sion of GATA-1 (Rekhtman et al., 1999). Thus, GATA-1
inhibition of PU.1 expression and/or function appearsPU.1 and GATA-2 Function in Concert to Regulate
Early Events in Mast Cell Differentiation to represent a critical regulatory switch underlying ery-
throid differentiation (Figure 7). Intriguingly, induction ofThe role of GATA-2 in mast cell development has been
most directly examined by establishing long-term yolk PU.1 activity in transformed avian multipotential progen-
itors promotes myeloid differentiation and down-regula-sac cultures from GATA-2/ embryos in IL-3 and SCF
(Tsai and Orkin, 1997). Under these conditions, GATA- tion of GATA-1 expression (Nerlov and Graf, 1998). Thus,
downregulation of GATA-1 by PU.1 appears to represent2/ yolk sac cells generate macrophages but not mast
cells. This in vitro system did not permit a detailed analy- a reciprocal regulatory switch for promoting macro-
phage differentiation (Figure 7).sis of GATA-2 function in mast cell development, since
GATA-2/ hematopoietic progenitors readily differen- We demonstrate that both the native PU.1 protein as
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phages generated by transduction of wild-type PU.1
cDNA into the PU.1/ cells (Figure 5C). Our results
demonstrate that repression of the GATA-2 gene by
PU.1 does not require the ets DNA binding domain,
thus ruling out direct binding of PU.1 to a regulatory
sequence in the GATA-2 gene. The amino-terminal seg-
ment of PU.1 which downregulates GATA-2 gene ex-
pression contains transcriptional activation domains as
well as the PEST region. Although the mechanism by
which the amino-terminal segment of PU.1 regulates
GATA-2 expression remains to be analyzed, an attrac-
tive possibility is suggested by the ability of this domain
to interact with GATA-2 (Zhang et al., 1999). Such an
interaction may impair GATA-2 function, which could
result in GATA-2 gene downregulation, assuming an au-
toregulatory loop.
Although reciprocal inhibitory interactions among
PU.1 and the GATA factors underlie the specification of
macrophage versus erythroid cell fates, we show that
the generation of mast cells is dependent on cooperative
Figure 7. A Developmental Model for the Cooperative and Antago- interplay between PU.1 and GATA-2 (Figure 7). In the
nistic Interplay between PU.1 and GATA Factors in the Specification mast lineage, PU.1 not only fails to repress GATA-2
of Hematopoietic Cell Fates
gene activity, but appears to coordinately function with
The model depicts the crossregulatory interactions among GATA-1,
GATA-2 in regulating mast cell-specific gene expres-GATA-2, and PU.1, in the development of erythrocytes, macro-
sion. How PU.1-mediated inhibition of GATA-2 gene ex-phages, and mast cells from a common multipotential progenitor.
pression is circumvented in mast lineage cells is a keyIn contrast to the antagonistic roles of GATA factors and PU.1 in
macrophage and erythrocyte development, these regulators coop- issue that requires further experimentation. It is possible
erate to enable specification of the mast cell lineage. Sizes of fonts that high levels of PU.1 expression or activity are re-
for GATA-1,2 and PU.1 symbolize relative levels of expression and/ quired for inhibiting GATA-2 gene expression. In this
or activity states.
view, graded levels or activity of PU.1 could be used to
specify mast versus macrophage cell fates. Differing
levels of PU.1 have been shown to promote B lympho-well as its PUER derivative can downregulate GATA-2
cyte versus macrophage development (DeKoter andgene expression during monocytic development (Fig-
Singh, 2000). Our results clearly establish that both an-ures 5B and 5C). We suggest a novel regulatory function
tagonistic as well as cooperative interplay between he-of PU.1, i.e., downregulation of GATA-2 gene expression
matopoietic transcription factors can be used to specifyin the absence of overt myeloid differentiation. We note
distinct cell fates. Such duality of regulatory interactionsthat the IL-3-dependent PU.1/ progenitors express
permits a small set of transcription factors, acting inlow levels of GATA-1 transcripts and that PU.1 as well
combinatorial capacities, to specify multiple lineagesas PUER also represses GATA-1 gene activity (data not
from a common progenitor.shown). We propose that the inhibition of GATA-2 and
GATA-1 gene activity by PU.1 in a multipotential progen-
Experimental Proceduresitor is crucial in restricting the developmental capacity
of this cell (Figure 7). Such a cell can no longer give rise Analysis of Embryonic Mast Cells and Their Progenitors
to erythrocytes, megakaryocytes, or mast cells since Day 16.5 PU.1 /, /, and / embryos were fixed in Bouin’s
solution, dehydrated, and embedded in paraffin. 7	m sections wereGATA-1 and/or GATA-2 (Tsai et al., 1994; Pevny et al.,
stained with acidified toluidine blue (Sigma). Metachromatic-stain-1995) are required for the development of these lin-
ing mast cells were counted along 1 cm regions of dorsal subcutane-eages. It should be noted that PU.1-mediated downreg-
ous tissue (Kitamura et al., 1979).ulation of the GATA-2 gene is probably necessary for
Methylcellulose colony-forming assays were performed on day
proper macrophage differentiation, as the conditional 14.5 embryonic fetal liver cells as described by DeKoter et al. (1998)
expression of GATA-2 in an ES cell system results in a using 10 ng/ml IL-3 and/or 100 ng/ml CSF. Colonies were stained
with Wright or toluidine blue to examine composition of cell types.block to macrophage development (Kitajima et al.,
2002). Our experiments demonstrate that the antagonis-
Establishment and Analysis of IL-3-Dependent PU.1/tic interplay between PU.1 and GATA-2 results in an
and / Cell Linesalteration of the developmental capacity of a multipoten-
Day 14.5 PU.1/ and / fetal liver progenitors were isolated
tial hematopoietic progenitor. We suggest that such in- and depleted of lineage-positive cells (CD4, CD5, CD8a, CD3,
teractions among hematopoietic regulatory genes in Gr-1, Ter119, and B220). Lineage-depleted (Lin) hematopoietic
progenitors were stimulated for 4 days in complete Iscove’s Modi-multipotential progenitors precede overt differentiation
fied Dulbecco’s Medium (IMDM) containing 10% fetal bovine serum,and represent molecular programming of specific devel-
50 	M -mercaptoethanol, 2 mM L-glutamine, 1 U/ml penicillin-opmental fates.
streptomycin, 100 ng/ml mSCF (Biosource), 10 ng/ml mIL-3 (Bio-How does PU.1 repress the activity of the GATA-2
source), and 10 ng/ml mIL-6 (R&D Systems). Cell lines were then
gene? We note that repression of the GATA-2 gene by established by maintaining cytokine-stimulated hematopoietic pro-
PU.1 is independent of the ERTM segment used in our genitors in complete IMDM medium containing only 5 ng/ml IL-3 at
cell densities between 105 and 106 cells/ml. After 60 days in culture,PUER fusion, as GATA-2 is downregulated in macro-
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PU.1/ cell lines were 
95% positive for FcRI. The PU.1/ cell provided by the University of Chicago Cancer Research Center core
facility.lines did not express FcRI nor the lineage-specific markers Ter119,
Mac-1, B220, or Thy-1; however, they did express low levels of Gr-1.
Western blots were performed as described by DeKoter et al. Received: November 20, 2001
(1998) using an affinity-purified anti-PU.1 antibody (Scott et al., Revised: October 1, 2002
1997), rabbit anti-TBP (Santa Cruz #sc-273), or anti-murine GATA-2
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